TransMedics: Trials Should Broaden OCS Adoption, Watch For Headwinds (Downgrade)
Source: SeekingAlpha
2026-03-09 13:05:33 ET
TransMedics' ( TMDX ) stock continues to trend higher, with investors seemingly becoming more comfortable with seasonality and growing competition. The company's financial performance also remains robust, and this should persist into 2026....
Read the full article on Seeking Alpha
For further details see:
TransMedics: Trials Should Broaden OCS Adoption, Watch For Headwinds (Downgrade)
TransMedics Group Inc.
NASDAQ: TMDX
TMDX Trading
0.13% G/L:
$130.0701 Last:
502,712 Volume:
$125.26 Open:
TMDX Latest News
March 08, 2026 05:42:00 am
TransMedics Stock Is Up 104% Over the Last Year: Is It Too Late to Buy for 2026?
February 28, 2026 12:50:00 pm
Got $5,000? TransMedics Could Be a High?Tech Organ Transplant Moonshot
TMDX Stock Data
$4,701,020,147
32,055,517
1.45%
174
N/A
Medical Equipment & Supplies
Healthcare
US
Andover
